| Pharmaceutical Information |
| Drug Name |
Ceftizoxime sodium |
| Drug ID |
BADD_D00403 |
| Description |
A semisynthetic cephalosporin antibiotic which can be administered intravenously or by suppository. The drug is highly resistant to a broad spectrum of beta-lactamases and is active against a wide range of both aerobic and anaerobic gram-positive and gram-negative organisms. It has few side effects and is reported to be safe and effective in aged patients and in patients with hematologic disorders. |
| Indications and Usage |
Cetizoxime was previously indicated for the treatment of infections due to susceptible strains of bacteria. |
| Marketing Status |
approved; withdrawn |
| ATC Code |
J01DD07 |
| DrugBank ID |
DB01332
|
| KEGG ID |
D00923
|
| MeSH ID |
D015296
|
| PubChem ID |
23663938
|
| TTD Drug ID |
D0Y7BD
|
| NDC Product Code |
Not Available |
| UNII |
26337D5X88
|
| Synonyms |
Ceftizoxime | Ceftizoxime Sodium | Sodium, Ceftizoxime | Ceftizoxime Monosodium Salt | Monosodium Salt, Ceftizoxime | Salt, Ceftizoxime Monosodium | SKF-88373 | SKF 88373 | SKF88373 | FR-13749 | FR 13749 | FR13749 | SK&F 88373-2 | SK&F 88373 2 | SK&F 883732 | Cefizox | FK749 | FK-749 | FK 749 |
|
| Chemical Information |
| Molecular Formula |
C13H12N5NaO5S2 |
| CAS Registry Number |
68401-82-1 |
| SMILES |
CON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=CCS3)C(=O)[O-].[Na+] |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
|
|
|
